Kyle Elrod

Kyle Elrod brings over 50 years of experience in the pharmaceutical, diagnostic, and life science industries to Asher Bio. Kyle currently serves as the Chief Operating Officer and is responsible for finance, human resources, IT facilities, and contract manufacturing operations.

Previously Kyle served as the Senior Vice President of Planning and Operations of Forty Seven Inc. (NASDAQFISV), where Kyle managed company operations, project management, human resources, and alliance management. Prior to Forty Seven Inc, Kyle spent eight years at Virobay in roles of increasing responsibility culminating in Senior Vice President of Project Management and Operations. In that role, he was responsible for alliance management, company operations and successfully brought three protease inhibitors into clinical trials.

Before Virobay, Kyle worked at Life Technologies as both an R&D Leader and a Program Director developing high throughput genetic sequencers. Prior to Life Technologies, he served in positions of increasing responsibility at Celera Pharmaceuticals in South San Francisco, culminating in a position as the Director of Research and Development Projects. During his 12 years at Celera, Kyle published over 22 scientific articles and was an inventor on four issued patents.

He received a B.A. in Microbiology and Immunology from the University of California, Berkeley.

Kyle joined Asher Bio because the team working on their cis-targeting technology is one of the best he's seen, and he is excited to see the technology move towards the clinic.